Research Portfolio
We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), research program area, and disease.
If you are interested in a specific research program area, browse the recently funded research by program area.
Filter for Grant pages
Keyword Search for Grant pages
Search Results
|
Title |
Institution |
Investigator |
Status |
Research Program Area |
| 01669-A: Determining the Role of Bacterial Infection in Complications after Chemotherapy | University of Wisconsin, Madison | Jonathan F Bach, DVM | Closed | Oncology |
| 01545-A: Pilot Study to Assess Folate Receptor Expression in Canine High-Grade Multicentric Lymphoma | Purdue University | Michael O. Childress, DVM, MS | Closed | Oncology - Lymphoma |
| 01542-A: The Effects of Baicalein on Canine Osteosarcoma Cells | Cornell University | Joseph J. Wakshlag, DVM, PhD | Closed | Oncology - Osteosarcoma |
| 01410A: Positional Cloning of Histiocytic Sarcoma (HS) in the Bernese Mountain Dog (BMD) and Flat Coated Retriever (Part A - See also 01410B) | National Human Genome Research Institute | Elaine A Ostrander, PhD | Closed | Oncology |
| 01429: Mechanistic Relationship of IL-8 in Cell Proliferation and Survival of Canine Hemangiosarcoma | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology - Hemangiosarcoma |
| 1418: Harnessing a Dog's Own Immune System to Kill Lymphoma Tumor Cells | Texas A&M Research Foundation | Heather M. Wilson, DVM | Closed | Oncology - Lymphoma |
| 01410B: Positional Cloning of Histiocytic Sarcoma (HS) in the Bernese Mountain Dog (BMD) and Flat Coated Retriever (Part B - See also 01410A) | CNRS - University of Rennes | Catherine Andre, PhD | Closed | Oncology |
| 01422: Targeting iNOS in Canine Oral Melanoma | University of Texas | Julie A. Ellerhorst, MD, PhD | Closed | Oncology |
| 01472: Enhanced Killing of Malignant Histiocytosis with a Novel Combination of Anti-Tumor Drugs | Colorado State University | Steven W. Dow, DVM, PhD | Closed | Oncology |
| 1484: Identification and Characterization of a Canine Derived Single Chain Antibody that Binds and Neutralizes Canine VEGF | University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Closed | Oncology - Hemangiosarcoma |
| 01426: Personalized Medicine for the Treatment of Canine Mast Cell Tumors | Colorado State University | Douglas H Thamm, VMD | Closed | Oncology |
| 01524-A: Leukocyte Oxidative Burst Activity in Peripheral Blood of Dogs with Lymphoma | University of Missouri, Columbia | Sandra M Axiak, DVM | Closed | Oncology - Lymphoma |
| 01503-A: Rational Development of Targeted Therapy - Aurora Kinase Inhibition in Osteosarcoma | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology - Osteosarcoma |
| 01494-A: Identifying the cause of drug resistance in canine lymphoma | Louisiana State University | Bonnie L. Boudreaux, DVM | Closed | Oncology - Lymphoma |
| 01502-A: Myxoma Virus Oncolytic Therapy in Mouse Models of Canine Cancer | University of Illinois | Amy L MacNeill, DVM, PhD | Closed | Oncology |
| 01490-A: Evaluation of Aurora kinase inhibitors in canine lymphoma in vitro | Louisiana State University | Keijiro Shiomitsu, D.V.M. | Closed | Oncology - Lymphoma |
| 01384-A: Improved Imaging to Monitor Therapy Response of Urinary Bladder Cancer Using 3D Volume Ultrasonography | Purdue University | James F. Naughton, DVM | Closed | Oncology |
| 01336B: Finding the Mutations that Increase Susceptibility to Transitional Cell Carcinoma in the Scottish Terrier, West Highland Terrier, and Shetland Sheepdog | National Human Genome Research Institute | Elaine A Ostrander, PhD | Closed | Oncology |
| 01093A: Positional Cloning of the Gene(s) for Gastric Cancer in the Chow Chow | National Human Genome Research Institute | Elaine A Ostrander, PhD | Closed | Oncology |
| 01336A: Finding the Mutations that Increase Susceptibility to Transitional Cell Carcinoma in the Scottish Terrier, West Highland Terrier, and Shetland Sheepdog | Purdue University | Deborah Knapp, DVM | Closed | Oncology |
| 01131: Genetic Background and the Angiogenic Phenotype in Cancer | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology - Hemangiosarcoma |
| 01376-A: Immunohistochemical Detection of Retinoid Receptor Alpha (RARa) in Naturally Occurring Cases of Cutaneous Mast Cell Tumors in Dogs | University of Missouri, Columbia | Carlos H. de M. Souza, DVM | Closed | Oncology |
| 01317: Mutation Detection and Functional Analysis of Multiple Loci for Osteosarcoma | Broad Institute | Kerstin Lindblad-Toh, PhD | Closed | Oncology - Osteosarcoma |
| 01355-A: Expression of Vascular Endothelial markers in Canine Hemangiosarcoma and their use in Diagnostic Cytology Using Immunocytochemistry | University of Illinois | Anne M Barger, DVM | Closed | Oncology - Hemangiosarcoma |
| 01344-A: Comparison of percentage of T regulatory cells in dogs with spontaneously occurring lymphoma following oral versus intravenous cyclophosphamide | University of Missouri, Columbia | Kimberly A. Selting, DVM | Closed | Oncology - Lymphoma |
| 01232-A: Investigation of NF-kB as a Therapeutic Target in Canine Lymphoma | University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Closed | Oncology - Lymphoma |
| 01226-A: Evaluation of Multidrug Resistance Genes in Primary Canine Lymphoma Cells Exposed to Enrofloxacin and Prednisolone | Auburn University | Annette N. Smith, DVM | Closed | Oncology - Lymphoma |
| 01147: Identifying Mutations in Genes Associated with Canine Hemangiosarcoma | Tufts University | Chieko Azuma, DVM PhD | Closed | Oncology - Hemangiosarcoma |
| 01113: Canine Non-Hodgkin Lymphoma: Characterization and Prognostic Value of Cancer Stem Cells | University of Minnesota | Timothy D. O'Brien, DVM, PhD | Closed | Oncology - Lymphoma |
| 1130: Measurement of Minimal Residual Disease Using Real Time PCR in Canine Lymphoma | Colorado State University | Susan E. Lana, DVM | Closed | Oncology - Lymphoma |
| 01152: Liposomal Bisphosphonate Therapy for Malignant Histiocytosis | Colorado State University | Steven W. Dow, DVM PhD | Closed | Oncology |
| 01139: Immune Targeting of Canine Hemangiosarcoma Using a Canine Derived Single Chain Antibody Approach | University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Closed | Oncology - Hemangiosarcoma |
| 00935A: Positional Cloning of Two Genes for Malignant Histiocytosis (MH) in the Bernese Mountain Dog | National Human Genome Research Institute | Elaine A Ostrander, PhD | Closed | Oncology |
| 01192-A: Metabolism and Action of Gemcitabine in Canine Osteosarcoma Cell Lines | University of California, Davis | Carlos O. Rodriguez Jr, DVM, PhD | Closed | Oncology - Osteosarcoma |
| 01194-A: Role of Hypoxia-Related Factors in Dog Glioblastoma Invasion | Texas A&M University | George Stoica, DVM, PhD | Closed | Oncology |
| 00935B: Positional Cloning of Two Genes for Malignant Histiocytosis (MH) in the Bernese Mountain Dog | CNRS - University of Rennes | Catherine Andre, PhD | Closed | Oncology |
| 00615B: Heritable and Sporadic Genetic Lesions in Canine Lymphoma | North Carolina State University | Matthew Breen, PhD | Closed | Oncology - Lymphoma |
| 00613: The Prognostic Significance of Chromosome Aneuploidy in Canine Lymphoma | North Carolina State University | Matthew Breen, PhD | Closed | Oncology - Lymphoma |
| 00947A: Heritable and Sporadic Genetic Lesions in Canine Osteosarcoma | North Carolina State University | Matthew Breen, PhD | Closed | Oncology |
| 01046-A: The Relevance of Ezrin in the Metastatic Progression of Canine Osteosarcoma | National Cancer Institute | Sung Hyeok Hong, DVM, PhD | Closed | Oncology - Osteosarcoma |
| 01178-A: Radiosensitization of Canine Osteosarcoma with Rapamycin | University of California, Davis | Michael S. Kent, DVM | Closed | Oncology - Osteosarcoma |
| 01187-A: The Role of mTOR in Canine Lymphoma | University of California, Davis | Michael S. Kent, DVM | Closed | Oncology - Lymphoma |
| 00947B: Heritable and Sporadic Genetic Lesions in Canine Osteosarcoma | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology - Osteosarcoma |
| 01168-A: Identifying Mutations in Genes Associated with Canine Hemangiosarcoma: Denser Fine Mapping of the Associated Locus in Chromosome 5 | Tufts University | Chieko Azuma, DVM, PhD | Closed | Oncology - Hemangiosarcoma |
| 01175-A: Pilot Investigation of the Causes of Hemangiosarcoma in Clumber Spaniels | Van Andel Research Institute | Nicholas S. Duesbery, PhD | Closed | Oncology - Hemangiosarcoma |
| 01169-A: Identifying Mutations in Genes Associated with Canine Hemangiosarcoma: Denser Fine Mapping of the Associated Locus in Chromosome 26 | Tufts University | Chieko Azuma, DVM, PhD | Closed | Oncology - Hemangiosarcoma |
| 976: Investigating the Role of STAT3 Activation in Canine Osteosarcoma | Ohio State University | Cheryl A. London, DVM PhD | Closed | Oncology - Osteosarcoma |
| 982: Evaluation of Efficacy of Fasaret in Dogs with Osteosarcoma | ApopLogic Pharmaceuticals, LLC | Don Bellgrau, Ph.D. | Closed | Oncology - Osteosarcoma |
| 01064-A: Immunocytochemical Detection and siRNA-Mediated Knockdown of Survivin in Canine Lymphoma | Colorado State University | Douglas H Thamm, VMD | Closed | Oncology |
| 01054-A: Adult NeurogenesisA Source of Dog Glioblastoma Multiforme (GBMs) Brain Tumor Development | Texas A&M University | George Stoica, DVM, PhD | Closed | Oncology |
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
